SUZHOU KINTOR PHARMACEUTICALS INC has a total of 29 patent applications. It decreased the IP activity by 78.0%. Its first patent ever was published in 2010. It filed its patents most often in China, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO LTD, ASCENEURON SA and XI NING.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 5 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Australia | 3 | |
#5 | Canada | 3 | |
#6 | Republic of Korea | 3 | |
#7 | United States | 3 | |
#8 | Brazil | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods | |
#5 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Tong Youzhi | 21 |
#2 | Zhang Xiaohu | 8 |
#3 | Guo Chuangxing | 8 |
#4 | Guo Chuangxin | 3 |
#5 | Lai Luhua | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021004391A1 | C-myc protein inhibitor, and preparation method therefor and use thereof | |
US2020002337A1 | Dihydropyridophthalazinone compounds as inhibitors of poly (adp-ribose) polymerase (parp) for treatment of diseases and method of use thereof | |
CN109790156A | Chiral heterocycle compound with activity of hedgehog path antagonist and its preparation method and application | |
KR20190020122A | Mechanical targeting of rapamycin signaling pathway inhibitors and its therapeutic application | |
CN106810542A | A kind of crystal formation, salt form of thiocarbamoyl imidazole alkanone compound and preparation method thereof | |
EP2945623A1 | Hedgehog pathway signaling inhibitors and therapeutic applications thereof | |
AU2012225038A1 | Androgen receptor antagonists and uses thereof | |
EP2475647A1 | Androgen receptor antagonists and uses thereof |